KYKOF
Price
$17.13
Change
+$2.38 (+16.14%)
Updated
Jul 28 closing price
Capitalization
9.03B
NVSEF
Price
$121.91
Change
-$4.88 (-3.85%)
Updated
Aug 25 closing price
Capitalization
244.54B
Interact to see
Advertisement

KYKOF vs NVSEF

Header iconKYKOF vs NVSEF Comparison
Open Charts KYKOF vs NVSEFBanner chart's image
Kyowa Hakko Kogyo
Price$17.13
Change+$2.38 (+16.14%)
Volume$153
Capitalization9.03B
Novartis AG
Price$121.91
Change-$4.88 (-3.85%)
Volume$241
Capitalization244.54B
KYKOF vs NVSEF Comparison Chart in %
Loading...
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYKOF vs. NVSEF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYKOF is a Buy and NVSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (KYKOF: $17.13 vs. NVSEF: $121.91)
Brand notoriety: KYKOF and NVSEF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: KYKOF: 31% vs. NVSEF: 2%
Market capitalization -- KYKOF: $9.03B vs. NVSEF: $244.54B
KYKOF [@Pharmaceuticals: Major] is valued at $9.03B. NVSEF’s [@Pharmaceuticals: Major] market capitalization is $244.54B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYKOF’s FA Score shows that 1 FA rating(s) are green whileNVSEF’s FA Score has 2 green FA rating(s).

  • KYKOF’s FA Score: 1 green, 4 red.
  • NVSEF’s FA Score: 2 green, 3 red.
According to our system of comparison, NVSEF is a better buy in the long-term than KYKOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYKOF’s TA Score shows that 5 TA indicator(s) are bullish while NVSEF’s TA Score has 5 bullish TA indicator(s).

  • KYKOF’s TA Score: 5 bullish, 3 bearish.
  • NVSEF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYKOF is a better buy in the short-term than NVSEF.

Price Growth

KYKOF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while NVSEF (@Pharmaceuticals: Major) price change was -3.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.92%. For the same industry, the average monthly price growth was +1.19%, and the average quarterly price growth was +11.79%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.92% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($245B) has a higher market cap than KYKOF($9.03B). KYKOF has higher P/E ratio than NVSEF: KYKOF (34.38) vs NVSEF (17.77). NVSEF YTD gains are higher at: 26.857 vs. KYKOF (14.200). KYKOF has higher annual earnings (EBITDA): 93.2B vs. NVSEF (22.7B). KYKOF has more cash in the bank: 236B vs. NVSEF (7B). KYKOF has higher revenues than NVSEF: KYKOF (493B) vs NVSEF (55.2B).
KYKOFNVSEFKYKOF / NVSEF
Capitalization9.03B245B4%
EBITDA93.2B22.7B411%
Gain YTD14.20026.85753%
P/E Ratio34.3817.77193%
Revenue493B55.2B893%
Total Cash236B7B3,371%
Total DebtN/A32.6B-
FUNDAMENTALS RATINGS
KYKOF vs NVSEF: Fundamental Ratings
KYKOF
NVSEF
OUTLOOK RATING
1..100
4513
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVSEF's Valuation (13) in the null industry is in the same range as KYKOF (18). This means that NVSEF’s stock grew similarly to KYKOF’s over the last 12 months.

NVSEF's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for KYKOF (100). This means that NVSEF’s stock grew significantly faster than KYKOF’s over the last 12 months.

NVSEF's SMR Rating (100) in the null industry is in the same range as KYKOF (100). This means that NVSEF’s stock grew similarly to KYKOF’s over the last 12 months.

NVSEF's Price Growth Rating (50) in the null industry is in the same range as KYKOF (50). This means that NVSEF’s stock grew similarly to KYKOF’s over the last 12 months.

NVSEF's P/E Growth Rating (100) in the null industry is in the same range as KYKOF (100). This means that NVSEF’s stock grew similarly to KYKOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KYKOFNVSEF
RSI
ODDS (%)
Bearish Trend 3 days ago
18%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 4 days ago
33%
Bullish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
23%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
28%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
50%
Declines
ODDS (%)
N/A
Bearish Trend 30 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
20%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
32%
Bearish Trend 2 days ago
34%
View a ticker or compare two or three
Interact to see
Advertisement
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTC5.380.20
+3.79%
Astrotech Corp
RRGB6.500.02
+0.31%
Red Robin Gourmet Burgers
TCPC7.13-0.02
-0.28%
BlackRock TCP Capital Corp
PRKS51.56-0.54
-1.04%
United Parks & Resorts
GFS33.58-0.39
-1.15%
GlobalFoundries

KYKOF and

Correlation & Price change

A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYKOF
1D Price
Change %
KYKOF100%
N/A
OPHLY - KYKOF
12%
Poorly correlated
+2.77%
NVSEF - KYKOF
7%
Poorly correlated
N/A
GIKLY - KYKOF
4%
Poorly correlated
N/A
MAYNF - KYKOF
-1%
Poorly correlated
N/A
HAWPF - KYKOF
-1%
Poorly correlated
N/A
More

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
N/A
SNYNF - NVSEF
27%
Poorly correlated
N/A
SNY - NVSEF
21%
Poorly correlated
-0.34%
NVS - NVSEF
20%
Poorly correlated
-0.33%
KYKOF - NVSEF
7%
Poorly correlated
N/A
GIKLY - NVSEF
6%
Poorly correlated
N/A
More